贲门癌不同手术径路的临床结果比较研究

doi:10.3969/j.issn.2095-378X.2022.04.002

外科研究与新技术 ›› 2022, Vol. 11 ›› Issue (4): 227-231.doi: 10.3969/j.issn.2095-378X.2022.04.002

贲门癌不同手术径路的临床结果比较研究

袁荣华¹, 于晓强², 王春战², 夏春秋², 仲崇俊², 黄海涛²

1.南通大学附属第二医院,南通市第一人民医院胃肠外科,江苏南通 226001;
2.南通大学附属第二医院,南通市第一人民医院胸心血管外科,江苏南通 226001

收稿日期:2022-10-12 出版日期:2022-12-28 发布日期:2023-03-20
通讯作者: 黄海涛,电子信箱：hht1979@126.com
作者简介:袁荣华（1977—）,男,大学本科,副主任医师,从事胃肠外科工作

Comparative study of clinical outcomes of different surgical approaches for cardiac cancer

YUAN Ronghua¹, YU Xiaoqiang², WANG Chunzhan², XIA Chunqiu², ZHONG Chongjun², HUANG Haitao²

1. Department of Gastrointestinal Surgery, Nantong First People's Hospital, Nantong University Second Affiliated Hospital, Nantong 226001, Jiangsu, China;
2. Department of Thoracic and Cardiovascular Surgery, Nantong First People's Hospital, Nantong University Second Affiliated Hospital, Nantong 226001, Jiangsu, China

Received:2022-10-12 Online:2022-12-28 Published:2023-03-20

摘要/Abstract

摘要： 目的比较研究经腹及经胸两种不同术式治疗贲门癌的临床结果。方法选取2014年1月—2017年12月收治的贲门癌患者198例,以手术方式不同分为研究组（经腹贲门癌切除者）108例和对照组（经左胸贲门癌切除者）90例。统计两组患者的一般临床资料,分析比较两组患者手术时间、术中及术后出血量、术后并发症、淋巴结清扫率,切缘的阳性率,TNM（Tumor Node Metastasis）临床分期、住院死亡率、平均住院时间,术后5年随访结果等。结果两组患者临床一般资料比较差异无统计学意义（P>0.05）。研究组在手术时间、术中及术后出血量、术后并发症、淋巴结清扫率,平均住院时间方面优于对照组,差异有统计学意义（P<0.05）。研究组在切缘的阳性率与对照组相当,两组均能达到完整切除,两组5年生存率统计学未见明显差异（P>0.05）。结论经胸贲门癌根治术虽然能够增加食管下段切除的长度、清扫纵膈淋巴结,但该术式术后并发症发生率高,手术创伤较大,术后5年生存率改善不明显,因此经腹手术推荐应用于本组贲门癌患者。

关键词: 贲门癌, 经胸手术, 经腹手术

Abstract: Objective To compare the clinical outcomes of patients with cardiac cancer undergoing radical resection by laparotomy or thoracotomy. Methods A total of 198 patients with cardiac cancer were selected from January 2014 to December 2017. Among them, 108 patients in the study group received trans-abdominal cancer resection and 90 patients in the control group received trans-thoracic cancer resection. General clinical characteristics, surgery time, intraoperative and postoperative hemorrhage volumes, postoperative complications, lymph nodes resection rate, positive surgical margins, tumor node metastasis （TNM） stages, hospital mortality rate, hospital stay, and 5-year survival were compared between the two groups. Results No significant difference was found in general clinical characteristics （P>0.05）. Compared with the control group, the surgery time, intraoperative and postoperative hemorrhage volumes, postoperative complication rate, lymph nodes resection rate, and hospital stay were superior in the study group （P<0.05）. No difference in positive surgical margin rate was found between the two groups, both with complete resection. There was no significant difference in 5-year survival rate between the two groups （P>0.05）. Conclusion Complications more frequently happen, operative trauma is larger, and 5-year survival is not increased after trans-thoracic cardiac cancer resection, though more esophagus and mediastinal lymph nodes can be removed. Therefore, trans-abdominal cardiac cancer resection is recommended.

Key words: Cardiac cancer, Trans-abdominal operation, Trans-thoracic operation

中图分类号:

R656.6

袁荣华, 于晓强, 王春战, 夏春秋, 仲崇俊, 黄海涛. 贲门癌不同手术径路的临床结果比较研究[J]. 外科研究与新技术, 2022, 11(4): 227-231.

YUAN Ronghua, YU Xiaoqiang, WANG Chunzhan, XIA Chunqiu, ZHONG Chongjun, HUANG Haitao. Comparative study of clinical outcomes of different surgical approaches for cardiac cancer[J]. Surgical Research and New Technique, 2022, 11(4): 227-231.

参考文献

[1] Hasegawa S, Yoshikawa T.Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies[J]. Gastric Cancer, 2010,13(2): 63-73.
[2] Kurokawa Y, Sasako M, Doki Y.Treatment approaches to esophagogastric junction tumors[J]. Dig Surg, 2013,30(2):169-173.
[3] Jung KW, Song HJ, Choi KD, et al.Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification[J]. Dis Esophagus,2009,22(8):676-681.
[4] Orditura M, Galizia G, Lieto E, et al.Treatment of esophagogastric junction carcinoma: an unsolved debate[J]. World J Gastroenterol, 2015,21(15):4427-4431.
[5] Tang A, Sohal D, McNamara M, et al. Siewert Ⅲ adenocarcinoma: still searching for the right treatment combination[J]. Surg Oncol Clin N Am, 2020,29(4):647-653.
[6] Siewert JR, Feith M, Werner M, et al.Adenocarcinoma of the esophagogastric junction[J]. Scand J Surg, 2000, 232(3): 353-361.
[7] Urabe M, Ushiku T, Shinozaki-Ushiku A, et al.Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: a comparative analysis according to Siewert classification in a Japanese cohort[J]. Cancer Med, 2018,7(10):5145-5154.
[8] Urakawa N, Kanaji S, Suzuki S, et al.Prognostic and clinicopathological significance of lymph node metastasis in the esophagogastric junction adenocarcinoma[J]. Anticancer Res, 2022,42(2):1051-1057.
[9] Mitchell KG, Ikoma N, Nelson DB, et al.Mediastinal nodal involvement after neoadjuvant chemoradiation for Siewert Ⅱ/Ⅲ adenocarcinoma[J]. Ann Thorac Surg, 2019,108(3):845-851.
[10] Hölscher AH, Law S.Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type Ⅱ, and Nishi types EG, E=G and GE cancers[J]. Gastric Cancer, 2020,23(1):3-9.
[11] Cao J, Yang T, Wang G, et al.Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction[J]. Surg Oncol, 2018 ,27(3):556-562.
[12] Siewert JR, Feith M, Stein HJ.Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification[J]. J Surg Oncol, 2005,90(3):139-146.
[13] Sugita S, Kinoshita T, Kaito A, et al.Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J]. Surg Endosc, 2018,32(1):383-390.
[14] 尤朵,赵学科,魏梦霞,等.贲门癌患者术前白蛋白水平与临床病理指标及预后的关系[J].食管疾病,2022,4(1):37-41.
[15] Raa ST, Oosterling SJ, van der Kaaij NP, et al. Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters[J]. J Surg Oncol, 2005, 92(2): 124-129.
[16] 黄洁,汪海峡.不同入路下根治术对高龄贲门癌患者围手术期指标及免疫功能的影响[J].现代实用医学,2019,31(12):1576-1578.
[17] 李爱华,闫元,龚云翔.经腹与经胸贲门癌根治术治疗贲门癌患者的效果及对免疫功能的影响[J].中外医学研究,2022,20(6):37-40.
[18] Tai LH, de Souza CT, Bélanger S, et al. Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells[J]. Cancer Res, 2013, 73(1):97-107.

贲门癌不同手术径路的临床结果比较研究

Comparative study of clinical outcomes of different surgical approaches for cardiac cancer

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	夏扣柱, 张健, 窦豆, 徐明. 腹腔镜辅助胃癌D2根治术治疗进展期胃癌对比观察[J]. 外科研究与新技术, 2021, 10(2): 104-106.
[2]	鲁科翔(综述), 范跃祖, 张景涛(审校). 十二指肠乳头旁憩室的临床诊疗进展[J]. 外科研究与新技术, 2012, 1(1): 87-90.